SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-246915
Filing Date
2021-08-16
Accepted
2021-08-16 07:21:54
Documents
14
Period of Report
2021-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d220784d8k.htm   iXBRL 8-K 32712
2 EX-10.1 d220784dex101.htm EX-10.1 94435
3 EX-99.1 d220784dex991.htm EX-99.1 13142
  Complete submission text file 0001193125-21-246915.txt   304191

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20210816.xsd EX-101.SCH 2879
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20210816_lab.xml EX-101.LAB 18887
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20210816_pre.xml EX-101.PRE 11851
7 EXTRACTED XBRL INSTANCE DOCUMENT d220784d8k_htm.xml XML 3520
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 211174495
SIC: 2834 Pharmaceutical Preparations